| # |
Company Name
|
Industry Name
|
Latest Price (Rs.)
|
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma. Inds. | Pharmaceuticals& Drugs | 1,951.3 |
-1.15 (-0.06%) |
Large Cap | 58,462 | 47.8 | 19.86 | 40.8 | 5.6 | |
| Cipla | Pharmaceuticals& Drugs | 1,428 |
-9.95 (-0.69%) |
Large Cap | 28,163 | 48 | 13.45 | 30 | 3.4 | |
| Torrent Pharma | Pharmaceuticals& Drugs | 5,002.8 |
-15.15 (-0.3%) |
Large Cap | 13,980 | 63.9 | 16.41 | 78.5 | 20.3 | |
| Divis Laboratories | Pharmaceuticals& Drugs | 7,319.8 |
35.15 (0.48%) |
Large Cap | 9,360 | 96.7 | 23.08 | 75.3 | 11.5 | |
| Apollo Hospital Ent. | Hospital &HealthcareServices | 8,889 |
-44.85 (-0.5%) |
Large Cap | 8,202 | 103.8 | 15.81 | 86.1 | 12.9 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: